Blog
e-Projection was certified as a company promoting teleworking
The COVID-19 pandemic forced even more adoption of telework and sparked a nationwide focus on telework as an important tool for safely and efficiently delivering missions in the public and private sectors. https://www.telework-rule.metro.tokyo.lg.jp/search/details.php?app_form_id=126919 Tokyo teleworking promotion certification is a program in which the Tokyo metropolitan government certifies companies that promote teleworking. In order to be […]
The BIOTECH SHOWCASE 2022 is delivered in a 100% virtual format
We have longed for live event for about two years, but this year the Biotech SHOWCASE goes 100% virtual. Although it is a pity that we have to until the next chance, BIO-Europe Spring 2022, in order to meet you in person, we’re still excited to be active participants! We are a big fan of […]
Takeda’s Regenerative Therapy “Alofisel” Gets 5.62 Million Yen NHI price
The Central Social Insurance Medical Council (Chuikyo), an advisory board for the reimbursement system relating to public healthcare insurance, endorsed the listing of 16 new drugs with 12 ingredients at its general meeting on November 17th. The newly listed drugs included Takeda Pharmaceutical’s cell therapy Alofisel (darvadstrocel), with an NHI price of 5.62 million yen. […]
e-Projection is going to BIOTECH SHOWCASE 2022!
e-Projection will be attending the BIOTECH SHOWCASE 2022! This is an extraordinary opportunity for us to discuss about your strategy to expand your business globally!! For the upcoming Biotech Showcase 2022, there are two options to attend: Biotech Showcase will be delivered in San Francisco in-person January 10–12, 2022 and digitally January 17–19, 2022 on […]
e-Projection is going to BIO-Europe® 2021!
e-Projection will be attending the BIO-Europe® 2021! Join us in the virtual space this time, to discuss about your strategy to expand your business globally!! We are a big fan of the Bio conference and really miss the live event. However, the virtual experience went very smoothly and gives a sense of great effectiveness. A […]
e-Projection will deliver a lecture at Tokyo University of Science, Management of Technology
Tokyo University of science, Management of Technology is holding various seminars and Symposiums in order to promote the talent development in the field of management of technology. It is our honor to announce that our CEO, Tosh Nagate will deliver a lecture as a guest speaker there on “Sales forecast for pharmaceutical products and project valuation” . Not only […]
e-Projection is going to Bio Japan in Yokohama
e-Projection is participating in the BioJapan, which is a part of Asia’s largest partnering event. This event is constituted by three exhibitions – 1. The world’s oldest biotechnology exhibition “BioJapan”, 2. “Regenerative Medicine JAPAN”, aiming to accelerate and industrialize R&D in the field of regenerative medicine including iPS cells, and 3.”health TECH JAPAN”, provides fusion […]
Post event report: Online seminar “Update on the valuation of pharmaceuticals in the Covid-19 world”
e-Projection held an online seminar on September 10th, 2021. This seminar titled “Update on the valuation of pharmaceuticals in the Covid-19 world ” brought together more than 100 representatives from Japanese pharmaceutical companies. The speaker this time was our CEO, Toshi Nagate and he spoke about the valuation of development project from comprehensive aspect […]
New Drugs Added to NHI Price List on August 12
The Central Social Insurance Medical Council (Chuikyo), an advisory board for the reimbursement system relating to public healthcare insurance, endorsed the listing of 23 new drugs with 15 ingredients at its general meeting on August 4. These new joined the NHI price list on August 12, including Chugai Pharmaceutical’s Evrysdi (risdiplam), which marks the first […]
To Be, or Not to Be in Japan, That is the Problem
Consider involving Japan in your drug development program, and start thinking about it now Globalization in the pharmaceutical industry is an ongoing and never ending process due to the monotonically increasing desire of people all over the world to gain faster access to healthcare innovation, fueled by the tireless efforts of the drug manufacturers to […]
